Opposition to Dr. Heidi Overton as Commissioner of the Food and Drug Administration (FDA)

370 health care professionals urge senators to oppose Dr. Heidi Overton’s FDA nomination.

OVERVIEW

Dr. Heidi Overton has been nominated to serve as Commissioner of the Food and Drug Administration (FDA). Her nomination is subject to consideration by the Senate Health, Education, Labor, and Pensions (HELP) Committee before advancing to the full U.S. Senate for a confirmation vote.

Physicians for Reproductive Health and the National Abortion Federation sent a letter to members of the Senate HELP Committee urging them to oppose Dr. Overton’s nomination as Commissioner

In total, 370 health care professionals and provider signed on to oppose Dr. Overton and call out the threat she poses to sexual and reproductive health.

FROM THE LETTER

“As providers in the reproductive health field, we believe Dr. Overton lacks the integrity and commitment to evidence-based research required to lead the FDA. If she is confirmed as FDA commissioner, we believe she would undermine the FDA’s credibility, threaten access to reproductive health care, and endanger public health at large.”

“The FDA is responsible for protecting and promoting public health by ensuring the safety and effectiveness of drugs and other consumer goods. This goal is achieved through high-quality science and research, separate from politics. As medical providers, we rely on the FDA to provide accurate drug and health information that guides our work with patients. Dr. Overton’s record proves she does not rely on scientific evidence and reason, but on a political agenda to restrictsexual and reproductive health care.”